Hedge funds vs. Chamath, plus finding gems in overlooked mid-cap stocks
Hello everyone! Welcome to this weekly roundup of Investing stories from deputy editor Joe Ciolli. Please subscribe here to get this newsletter in your inbox every week.
Hello and welcome to Insider Investing. I'm Joe Ciolli, and I'm here to guide you through the current market and investing landscape. The newsletter will be taking a week off and returning on April 11. Here's what's on the docket:
- Chamath Palihapitiya's ongoing SPAC frenzy is being targeted by hedge funds, who have made $40 million this year betting against him. We provide a detailed look at the short wagers being made against Chamath's SPACs.
- Amy Zhang manages a fund that's generated a 138% return over the past year. She explains why the mid-cap equity space is teeming with opportunity, and shares 3 of her top stock picks.
- David Keller, the chief market strategist at Stockcharts.com and technical-analysis expert, shared with us the 4 charts to watch for crucial signs of what's to come in markets.
If you aren't yet a subscriber to Insider Investing, you can sign up here.
Have thoughts on the newsletter? Just want to talk markets? Feel free to drop me a line at jciolli@insider.com or on Twitter @JoeCiolli.
Check out our new investing e-book:
The definitive guide to picking long-term stock-market winners, according to America's top-ranked fund managers.
Investing editor Akin Oyedele showcases eight star fund managers, their performance highlights, and their five biggest stock holdings.
Hedge funds vs. Chamath
SPACs have been caught in a harsh sell-off along with growth stocks as bond yields rise. Billionaire Chamath Palihapitiya has been among those most affected, with short-sellers making $40 million betting against his SPACs year-to-date. We break down the wagers being made against Chamath's three most high-profile SPACs.
Read the full story here:
Hedge funds are ramping up bets against Chamath Palihapitiya's SPACs and have already taken home $40 million this year. Here's a detailed look at the wagers they're making.
The case for overlooked mid-cap stocks
Amy Zhang manages $11 billion across small- and mid-cap funds for Alger - one of which has generated a 138% return over the past year. She explains why the mid-cap equity space is teeming with opportunity, and shares 3 of her top stock picks.
Read the full story here:
A fund manager who's returned 138% in the past year shares 3 mid-cap stocks poised to surge as the economic reopening accelerates - and breaks down why investors should consider this overlooked yet outperforming asset class
4 charts for the future
David Keller is the chief market strategist at Stockcharts.com and an expert at technical analysis. We asked him what charts investors should be looking at now, and what they're indicating assets might do going forward. He responded with four that he dissected in detail.
Read the full story here:
A chief market strategist shares 4 must-see charts that forecast the next big moves in stocks, bonds, and gold - and 6 trades set to surge on what happens next
Stock pick central
Seeking experts who are willing to name names? Look no further:
- Goldman Sachs says to buy these 33 stocks that are set to generate the market's most explosive sales growth in 2021 as the COVID-slammed economy reopens
- Buy these 30 stocks that are best-placed to benefit from the pandemic's 'seismic shifts' and continue surging in its aftermath, BTIG says
- MORGAN STANLEY: Buy these 10 stocks quickly that will roar higher as M&A heats up - including one with a potential upside of 114%
- Buy these 49 stocks that are set to increase their dividend payouts to shareholders the most in 2021, Goldman Sachs says
- Cowen says buy these 10 retail stocks before a colossal wave of consumer spending sends them skyrocketing - including one expected to surge 71%
- Buy these 15 stocks that are set to surge as companies invest their near-record amounts of cash on massive infrastructure projects and technologies, Jefferies says
- Morgan Stanley shares 7 bank stocks set to be among the biggest winners of the market's vast rotation into cheaper names - and lays out 5 reasons why they can continue outperforming